KAISER PETER (Chief Development Officer) received a stock award from OCULAR THERAPEUTIX, INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/6/2026ACC: 0001104659-26-001291
Officer· Chief Development Officer
Since Feb 2026
+320.04K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
320.04K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+79.11K
Price / share
—
Trade value
—
% of position
41.0%
1/2/2026
192.81K→271.92K
Total
Net shares
+79.11K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | A · Award | +79.11K | — | — | 41.0% | 192.81K | 271.92K |
| Total | +79.11K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
240.93K shares
Shares
+240.93K
Strike price
11.82
Held after
240.93K
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock240.93K shares | 1/2/2026 | A · Award | +240.93K | 11.82 | — | 240.93K |